메뉴 건너뛰기




Volumn 57, Issue 5, 2002, Pages 699-700

Antineutrophil cytoplasmic antibody associated vasculitis and rapidly progressive glomerulonephritis as a complication of propylthiouracil therapy [2]

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; LIOTHYRONINE; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THYROTROPIN;

EID: 0036420140     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2002.16412.x     Document Type: Letter
Times cited : (9)

References (1)
  • 1
    • 0035723690 scopus 로고    scopus 로고
    • Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations
    • Noh, J.H., Asari, T., Hamada, N., Abes, Y., Ito, K. & Ito, K. (2001) Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations. Clinical Endocrinology, 54, 651-654.
    • (2001) Clinical Endocrinology , vol.54 , pp. 651-654
    • Noh, J.H.1    Asari, T.2    Hamada, N.3    Abes, Y.4    Ito, K.5    Ito, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.